Triumvira Immunologics’ Partnership with Merck to Evaluate TAC01-HER2 Cell Therapy

Torys LLP acted as counsel to Triumvira Immunologics on the collaboration with Merck. On January 5, 2023, Triumvira Immunologics, Inc. (“Triumvira”) announced a clinical trial collaboration…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Sonia Carcano

Author: Sonia Carcano

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here